# Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants

> **NCT00574795** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 193 (actual)

## Conditions studied

- Vaccines, Pneumococcal Conjugate Vaccine

## Interventions

- **BIOLOGICAL:** 13vPnC

## Key facts

- **NCT ID:** NCT00574795
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2012-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574795, "Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00574795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*